Ms Annette Tognela

Research Fellow
NHMRC Clinical Trials Centre, Sydney Medical School

Telephone +61 2 99221783

Website Related website

Map

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Davidson, A., Veillard, A., Tognela, A., Chan, M., Huighes, B., Boyer, M., Briscoe, K., Begbie, S., Abdi, E., Crombie, C., Chinchen, S., Espinoza, D., Coskinas, X., Pavlakis, N., Stockler, M., et al (2015). A phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: the Australasian lung cancer trials group NITRO trial. Annals of Oncology, 26(11), 2280-2286. [More Information]
  • Tognela, A., Beith, J., Kiely, B., Bastick, P., Lynch, J., Descallar, J., Mok, K. (2015). Small HER2-positive breast cancer: Should size affect adjuvant treatment? Clinical Breast Cancer, 15(4), 277-284. [More Information]

2015

  • Davidson, A., Veillard, A., Tognela, A., Chan, M., Huighes, B., Boyer, M., Briscoe, K., Begbie, S., Abdi, E., Crombie, C., Chinchen, S., Espinoza, D., Coskinas, X., Pavlakis, N., Stockler, M., et al (2015). A phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: the Australasian lung cancer trials group NITRO trial. Annals of Oncology, 26(11), 2280-2286. [More Information]
  • Tognela, A., Beith, J., Kiely, B., Bastick, P., Lynch, J., Descallar, J., Mok, K. (2015). Small HER2-positive breast cancer: Should size affect adjuvant treatment? Clinical Breast Cancer, 15(4), 277-284. [More Information]

To update your profile click here. For support on your academic profile contact .